Xylazine in Timor-Leste: not individually verified

We have not confirmed that Xylazine specifically is scheduled in Timor-Leste, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record

Not confirmed. Xylazine is not named in any of Tables I to VI of Lei 2/2017's Anexo II, as at 25 January 2017, the date the law was published, searched directly under that name across all six tables and found in none. Xylazine is a veterinary alpha-2 adrenergic agonist sedative, with no recognized human medical use. It is not an opiate-derived or opiate-mimicking substance of the kind article 5, paragraph 2(a), describes for Table I-A, not a hallucinogen of the kind article 5, paragraph 2(d), describes for Table II-A, not an amphetamine-type stimulant of the kind article 5, paragraph 2(e), describes for Table II-B, and not a barbiturate-type or non-barbiturate hypnotic of the kind article 5, paragraph 2(f), describes for Table II-C; its adrenergic mechanism is pharmacologically distinct from every category those clauses describe, so none of the tables' own descriptive drafting criteria reads across to it. Only Decreto-Lei 2/2025 was checked as a candidate amending instrument and found not to amend the tables; no broader search of the Jornal da República 2017 to 2026 for a separate amending law has been completed, and no instrument closing the question the way a No Subsidiary Legislation line would has been located either. On that scope, this is NOT VERIFIED rather than a confirmed absence. Article 3, paragraph 3, claims the tables update automatically with United Nations scheduling changes; whether that self-executes is not resolved by the printed text, and the printed list's own gaps confirm it: mephedrone (Table II-A item 26) and MDPV were both placed under Schedule II of the 1971 Convention by the same Commission on Narcotic Drugs 58th session, 9 to 17 March 2015, yet only mephedrone is named in the 2017 printed text (Table IV item 54 names only Pirovalerona, MDPV's older, chemically different parent compound); that confirmed gap shows the printed text cannot be trusted as fully current even at its own enactment.

Confirm directly with Timor-Leste’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.